OTC · WILYY
Healthcare · Medical - Devices
$24.80
Up+$1.44 (+6.16%)
Updated Oct 12, 2026, 8:35 AM
SID Score
5.7/10
Composite research score
Smart Money
46/100
Neutral
Price performance · WILYY
1M range · 0 trading sessions · Daily adjusted prices
WILYY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning WILYY.
Company
Market Activity
Research & News
WILYY research
Company profile and research snapshot.
DEMANT HLDG U/ADR
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 23, 2026 | JEFFERIES | Buy | — |
| Sep 23, 2026 | JYSKE BANK | Hold | — |
| Aug 31, 2026 | BNP PARIBAS | Neutral | — |
| Aug 21, 2026 | EQUITA SIM | Hold | — |
| Aug 12, 2026 | DNB CARNEGIE | Buy | — |
No generated briefing is available yet.
Yahoo · Sep 25, 2026
Investing.com -- European medtech has had another bruising year, with only Demant and Sonova outperforming the Stoxx 600 in 2026 as the sector’s once-premium valuation continues to de-rate.
SeekingAlpha · Aug 12, 2026
Demant A/S (WILYY) Q2 2026 Earnings Call August 12, 2026 8:00 AM EDTCompany ParticipantsPeter Pudselykke - Head of Investor Relations (Leave of...
SeekingAlpha · Feb 4, 2026
SeekingAlpha · Feb 3, 2026
Demant A/S (WILYY) Q4 2025 Earnings Call February 3, 2026 8:00 AM ESTCompany ParticipantsPeter Pudselykke - Head of Investor Relations (Leave of...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning WILYY.
